Showing results (101-110 of 220) with videos related to

Sort By:
Pageof 22
Journal of Clinical Gastroenterology|July 11, 2006
Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn diseaseBruce E Sands, William J Sandborn, Douglas C Wolf, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2010
Continuous therapy with certolizumab pegol maintains remission of patients with Crohn's disease for up to 18 monthsGary R Lichtenstein, Ole Ø Thomsen, Stefan Schreiber, et al.
Case Reports in Gastroenterology|May 14, 2025
Cytomegalovirus Isolated to a Colon Polyp in a Patient with Ulcerative Colitis on Ozanimod: A Case ReportZehra Naseem, Ahmed Nadeem, Aidan J David, et al.
Nutrition and Healthy Aging|January 11, 2020
Reply to critique of "A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity"Sumit Bhattacharyya, Hui Xie, Amar Dodda, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 12, 2018
Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel diseaseAbhinav Vasudevan, Lauren Beswick, Antony B Friedman, et al.
Gastroenterology|September 14, 2004
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trialStephen B Hanauer, Burton I Korelitz, Paul Rutgeerts, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 28, 2017
Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical OutcomesBritt Christensen, Stephen B Hanauer, Jonathan Erlich, et al.
The American Journal of Gastroenterology|June 24, 2003
Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammationSunanda V Kane, William J Sandborn, Paul A Rufo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2004
Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's diseaseStephen B Hanauer, Carrie L Wagner, Mohan Bala, et al.
Gastroenterology|February 14, 2006
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trialStephen B Hanauer, William J Sandborn, Paul Rutgeerts, et al.
Pageof 22